This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The use of pharmaceutical cannabinoid products in Singapore comes under strict frameworks and regulations and does not diminish the country’s zero-tolerance position against drugs, the Home Affairs and Health ministries have said. ” At a Central Narcotics Bureau’s workplan seminar on May 24, Law and Home Affairs Minister K.
Noting her mother’s reduced pain and relief from other pharmaceutical side effects, she said, “I have to say, I’m kind of an advocate for it.” A nurse practitioner discusses legal and health-related aspects of cannabis, but evaluations and certifications aren’t conducted as part of the seminars. Gluchacki said.
Edited by renowned endocannabinoid researcher, Jahan Marcu, PhD, AJEM’s inaugural issue was published last month in conjunction with a medical education seminar put on by Havas at Columbia University. AJEM’s mission is to create, collect, and disseminate credible cannabis research data. Cannabis Law J. September 2017. Federal Register.
At the same time, the outlook on cannabis research data is largely positive. Data collection. One coder then independently coded the entire dataset and entered the data into NVivo v12. This offers a more denotative approach to complement the data. upcoming seminars). 11) rather than a plant product ( n ?=?4).
We do NORML legal seminars twice a year where attorneys from around the country can come and get the required continuing legal education credits, with a focus on cannabis, of course, our seminars. It’s not with volumes of data, and facts and figures. We have the NORML legal committee as well. EG: One of those ones.
Miller spent the months after this meeting leading hundreds of CBD seminars for farmers; Dr. Kerr began informal patient surveys to track how CBD made people feel; and as he finished his book, Mr. Lee often traveled around with Mr. Laughter and Mr. Police raids and federal prosecution of medical marijuana businesses were still common.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content